Abstract:Objective:To test the antibiotic susceptibility of vulvovaginal candidiasis pathogenic strains to 5 antifungal drugs commonly used in clinic.Methods:A total of 1 200 vulvovaginal candida patients from 23 gynecological and family planning outpatient departments in China were enrolled. Their vaginal secretions were collected for candida strain isolation and species identification. According to Clinical and Laboratory Standards Institute (CLSI) M27-S3, the sensitivity of 1 200 strains to clotrimazole, fluconazole, miconazole, itraconazole and nystatin was tested.Results:(1) The sensitivity and resistance of 1 200 vulvovaginal candidiasis pathogens to 5 antifungal drugs were statistically different ( χ2=3 513.201, P<0.01). (2) All strains had higher sensitivity to nystatin [99.92% (1 199/1 200)], followed by miconazole [92.25% (1 107/1 200)] and clotrimazole [87.17% (1 046/1 200)]. All strains had higher resistance to fluconazole [69.17% (830/1 200)], while itraconazole was 50.83% (610/1 200). (3) There was no significant difference between candida albicans and non-candida albicans in drug sensitivity to nystatin ( P=0.315) and miconazole ( P=0.425). (4) Candida albicans and non-candida albicans showed different sensitivity to clotrimazole, fluconazole and itraconazole, respectively. Compared with non-candida albicans, candida albicans showed higher sensitivity to clotrimazole [susceptibility rate: 73.01% (165/226) vs 90.45% (881/974); P<0.001] and higher resistance to fluconazole [resistance rate: 50.88% (115/226) vs 73.41% (715/974); P<0.001]. Although the drug sensitivity of itraconazole was not high, the susceptibility rate of candida albicans to itraconazole was slightly higher than that of non-candida albicans [37.68% (367/974) vs 23.89% (54/226)], and the drug resistance rate was lower [49.28% (480/974) vs 57.52% (130/226)]. Conclusions:The sensitivity of 1 200 strains of candida to 5 antifungal drugs is significantly different, the sensitivity rate of nystatin, miconazole and clotrimazole are higher, but the resistance rate of fluconazole and itraconazole are higher. The sensitivity of candida albicans and non-candida albicans to the same drug is also significantly different. It is suggested that in clinical diagnosis and treatment, we should pay attention to the identification of candida and drug sensitivity test, so as to select antifungal drugs rationally.

Antifungal Susceptibility Testing of Clinical Isolates of Candida Albicans to Terbinafine, Miconazole and Nystatin

Comparative Evaluation of ATB FUNGUS 3 Procedure and CLSI M27-A2 Broth Microdilution Method for Antifungal Susceptibility Testing of Pathogenic Yeasts

Comparative study on antifungal susceptibilities of hyphal form and yeast form of Candida albicans in vitro

In vitro activity of terbinafine in combinations with other antifungi drugs against clinical pathogenic fungi of vulvovaginal candidiasis

Antifungal Susceptibility Testing of 100 Clinical Isolates of Pathogenic Yeasts

Study on antifungal susceptibilities and resistance trends of 209 strains of C. albicans with various genotypes and filamentous fungi isolated from clinical specimens

Antifungal Susceptibility Testing of Commensal and Pathogenic Clinical Isolates of Oral Candida

Activities of Terbinafine in Combination with Itraconazole and Fluconazole Against Isolates of Candida albicans In Vitro

Susceptibility of 1070 Clinical Isolates of Candida Species to Three Antifungal Agents

Comparison of two approaches for observing susceptibility of antifungal agents to Candida species determined by microdilution method

Impacts of time,dimorphism and pH on antifungal susceptibility of candida albicans

Antifungal Susceptibility Testing of Candida Albicans Isolated from Recurrent Vulvovaginal Candidiasis

Observing the Susceptibility of Candida Albicans Challenge with Fluconazole and Itraconazole by M27-A Microdilution Method

Preliminary study of antifungal effect and mechanism of novel imidazoles 2-imidazole-2, 4-pentadienone 19 and 44 on Candida albicans

The sensitivity testing in vitro of major Candida to terconazole

Assaying the Susceptibility of Fluconazole-Resistant Candida Albicans to Common Antifungal Drugs

Analysis of Resistance and Sensitivity of 1 200 Strains of Vulvovaginal Candidiasis in China to Five Common Antifungal Drugs

Susceptibility Test by Berberine Hydrochloride Combined with Antifungal Agents Against Trichophyton Rubrum in Vitro

In-vitro susceptibility of 248 isolates of Candida sp. and Cryptococcus neoformans to four antifungal agents

In Vitro Antidrug Susceptibility Testing of Candida Species Isolated from Aseptic Body Fluids

Antifungal susceptibility test for pathogenic Fusarium spp in vitro